CMMB Earnings Date 2026
Chemomab Therapeutics Ltd DRC earnings schedule and quarterly results
Next Earnings Date
TBD
Current Stock Price
$2.83
+3.48% today
Earnings Metrics
EPS (TTM)
$-1.44
P/E Ratio
23.3
Revenue Growth
0.0%
Market Cap
$0.0B
Earnings History
| Quarter | EPS | Revenue | Net Income |
|---|---|---|---|
| Q4 2022 | $0.12 | - | $-0.03B |
| Q4 2021 | $0.06 | - | $-0.01B |
Trading Around CMMB Earnings
Before Earnings
- Review analyst expectations and consensus estimates
- Check options implied volatility for expected move
- Consider historical earnings surprises
- Monitor pre-announcement guidance
After Earnings
- Compare actual results to estimates
- Listen to the earnings call for guidance
- Watch for analyst rating changes
- Monitor institutional buying/selling
Get Full CMMB Analysis
DCF valuation, AI insights, and institutional ownership data
Frequently Asked Questions
When is CMMB next earnings date?
CMMB (Chemomab Therapeutics Ltd DRC) has not yet announced its next earnings date. Check back for updates on the upcoming earnings schedule.
What is CMMB earnings per share (EPS)?
CMMB's current earnings per share (EPS) is $-1.44. With a P/E ratio of 23.3, the market values each dollar of earnings at $23.3.
How often does CMMB report earnings?
Like most publicly traded US companies, CMMB (Chemomab Therapeutics Ltd DRC) reports earnings quarterly, typically within 4-6 weeks after each fiscal quarter ends. The company holds an earnings call to discuss results with analysts.
What time does CMMB report earnings?
CMMB typically reports earnings either before market open (BMO) or after market close (AMC). The exact time is usually announced a few days before the earnings date. Check the investor relations page for specific timing.
How has CMMB performed in recent earnings?
In the most recent quarter (Q4 2022), CMMB reported EPS of $0.12.
What do analysts expect for CMMB earnings?
Analyst expectations for CMMB earnings can vary. View the full analyst ratings page for detailed expectations.